Conference News

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

Share

The Retina World Congress is a gathering of leading experts in the field of retina and vitreous. It provides a platform for knowledge sharing, discussions on advancements in retinal care, and networking opportunities. The congress aims to enhance patient care by promoting collaboration and innovation among retina specialists and researchers.

Original Source(s)

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

  • by Jim Gallagher, senior managing editor

  • May 1, 2025

  • 5 min

Related Content

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA

PRISM Trial Update Presented at RWC

Mark Barakat, MD, provided an update on the PRISM clinical trial for 4D-150 (4DMT) for wet AMD at the Retina World Congress meeting in Fort Lauderdale.

Migaldendranib May Move the Needle in AMD, DME

Michael A. Singer, MD, shares early phase 2 data supporting D-4517.2 as a safe and effective subcutaneous therapy, reducing injection burden and preserving vision.